These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16321727)

  • 1. The schizophrenia prodrome: a developmentally informed review and update for psychopharmacologic treatment.
    Thomas LE; Woods SW
    Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):109-33. PubMed ID: 16321727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early intervention in patients at ultra high risk of psychosis: benefits and risks.
    de Koning MB; Bloemen OJ; van Amelsvoort TA; Becker HE; Nieman DH; van der Gaag M; Linszen DH
    Acta Psychiatr Scand; 2009 Jun; 119(6):426-42. PubMed ID: 19392813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of clinical characteristics and antipsychotic medication prescribing practices of first-episode schizophrenia in Israel: a naturalistic prospective study.
    Strous RD; Bar F; Keret N; Lapidus R; Kosov N; Chelben J; Kotler M
    Isr J Psychiatry Relat Sci; 2006; 43(1):2-9. PubMed ID: 16910378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on pharmacologic treatments for autism spectrum disorders.
    King BH; Bostic JQ
    Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):161-75. PubMed ID: 16321729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial differences in the use of adjunctive psychotropic medications for patients with schizophrenia.
    Mallinger JB; Lamberti SJ
    J Ment Health Policy Econ; 2007 Mar; 10(1):15-22. PubMed ID: 17417044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia.
    Quednow BB; Frommann I; Berning J; Kühn KU; Maier W; Wagner M
    Biol Psychiatry; 2008 Nov; 64(9):766-73. PubMed ID: 18514166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polypharmacy in the treatment of schizophrenia].
    Messer T; Tiltscher C; Schmauss M
    Fortschr Neurol Psychiatr; 2006 Jul; 74(7):377-91. PubMed ID: 16804806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specific features and problems in the pharmacotherapy of schizophrenic psychoses in children and adolescents].
    Fegert JM
    Z Arztl Fortbild Qualitatssich; 2002 Oct; 96(9):597-603. PubMed ID: 12474310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward a better identification and treatment of schizophrenia prodrome.
    Bota RG; Sagduyu K; Filin EE; Bota DA; Munro S
    Bull Menninger Clin; 2008; 72(3):210-27. PubMed ID: 18990056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for the long-term treatment of schizophrenia: real-world lessons from the CATIE trial.
    Meyer JM
    J Clin Psychiatry; 2007; 68 Suppl 1():28-33. PubMed ID: 17286525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clozapine in the treatment of under-age schizophrenia].
    Haapasalo-Pesu KM
    Duodecim; 2009; 125(15):1635-8. PubMed ID: 19769179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and safety of antipsychotic drugs during pregnancy.
    Einarson A; Boskovic R
    J Psychiatr Pract; 2009 May; 15(3):183-92. PubMed ID: 19461391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early intervention and the treatment of prodrome in schizophrenia: a review of recent developments.
    Mokhtari M; Rajarethinam R
    J Psychiatr Pract; 2013 Sep; 19(5):375-85. PubMed ID: 24042243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results.
    Novak Sarotar B; Pesek MB; Agius M; Kocmur M
    Neuro Endocrinol Lett; 2008 Dec; 29(6):990-4. PubMed ID: 19112411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence.
    Chan J; Sweeting M
    J Psychopharmacol; 2007 Aug; 21(6):657-64. PubMed ID: 17092976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The New York high risk project to the Hillside recognition and prevention (RAP) program.
    Cornblatt BA
    Am J Med Genet; 2002 Dec; 114(8):956-66. PubMed ID: 12457393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection.
    Lieberman JA; Malaspina D; Jarskog LF
    CNS Spectr; 2006 Apr; 11(4):suppl 1-13; quiz suppl 14-5. PubMed ID: 16641837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.